
Loading, please wait...

Loading, please wait...

Managing pediatric food allergies has undergone a significant transformation in recent years. Specifically, the introduction of oral immunotherapy (OIT) has drastically improved oral food challenge safety. Historically, oral food challenges (OFCs) carried a high risk of anaphylaxis. However, recent data suggests that OIT adoption helps clinicians select lower-risk patients for these procedures. This clinical shift has remarkably reduced the need for emergency interventions like epinephrine.
A retrospective cohort study conducted at BC Children’s Hospital compared outcomes from two distinct periods. Researchers analyzed data from the pre-OIT era (2014-2017) and the post-OIT era (2019-2021). Consequently, they discovered that patients in the post-OIT group had significantly lower odds of a positive challenge. The rate of positive OFCs dropped from 32.6% to 26.3% between these two eras. Furthermore, patients who underwent a challenge after reaching OIT maintenance levels were much safer.
In addition to fewer positive outcomes, the severity of reactions decreased during the post-OIT period. Notably, the odds of requiring epinephrine fell from 15.0% to 8.31%. Moreover, severe Grade 4 reactions became rare, occurring in only about 6% of positive cases. Therefore, the strategic integration of OIT allows for better risk stratification. As a result, practitioners can now offer challenges with much greater confidence in patient outcomes.
These improvements are likely multifactorial. Practice patterns have evolved to offer OFCs at more optimal times during the desensitization process. Because OIT raises the patient\'s reaction threshold, the immune system becomes less volatile. Consequently, even if a reaction occurs, it is typically milder than it would have been otherwise. This shift represents a major milestone in providing safer, more effective allergy care for children.
OIT gradually desensitizes the immune system to an allergen. This process increases the amount of a specific food a patient can tolerate before reacting. Consequently, the likelihood of severe anaphylaxis during a formal food challenge decreases significantly.
While the need for epinephrine has dropped by nearly half in the post-OIT era, it remains a critical safety tool. Clinical settings must always be prepared to manage reactions, even though the risk of severe outcomes is lower for patients on maintenance OIT.
The study found that reaction severity stayed low in the post-OIT era. Only a tiny fraction of positive challenges resulted in severe symptoms. This indicates that modern clinical practices effectively filter for lower-risk scenarios.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Sage AP et al. The shift towards lower-risk oral food challenges since the implementation of oral immunotherapy: a retrospective cohort study. Allergy Asthma Clin Immunol. 2026 Mar 29. doi: 10.1186/s13223-026-01028-y. PMID: 41906180.
American Academy of Allergy, Asthma & Immunology. Oral Immunotherapy for Food Allergy. 2024.
Waserman S et al. Management of anaphylaxis: ASIA (Allergy, Genes and Environment Network) and CSACI (Canadian Society of Allergy and Clinical Immunology) guidelines. 2023.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A retrospective study shows how oral immunotherapy (OIT) adoption has led to safer oral food challenges with lower rates of anaphylaxis and positive reactio...
6 months ago

Discover the crucial role of glymphatic dysfunction in stroke, where perivascular clearance failure and neuroinflammation exacerbate cerebral edema and post-stroke brain injury.
Today

A prenatal case highlights severe glutaric acidemia type II presenting as bilateral hyperechoic cystic kidneys at 18 weeks. Whole-exome sequencing revealed a novel homozygous ETFDH frameshift variant, demonstrating the power of rapid genetic testing in fetal renal anomalies.
Today

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Yesterday